EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Nutraceuticals known to promote hair growth do not interfere with the inhibitory action of tamoxifen in MCF7, T47D and BT483 breast cancer cell lines

Richard Baker iD, Giorgio Dell'Acqua, Aleksander Richards, M Julie Thornton

PLOS ONE · 2024

DOI: 10.1371/journal.pone.0297080 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Richard Baker und 3 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Skin Sciences, Faculty of Life Sciences, University of Bradford, Bradford, United Kingdom. Hauptthemen laut MEDLINE: Tamoxifen, Breast Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Nutraceutical Wellness, Inc..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hair loss/thinning is a common side effect of tamoxifen in estrogen receptor (ER) positive breast cancer therapy. Some nutraceuticals known to promote hair growth are avoided during breast cancer therapy for fear of phytoestrogenic activity. However, not all botanical ingredients have similarities to estrogens, and in fact, no information exists as to the true interaction of these ingredients with tamoxifen. Therefore, this study sought to ascertain the effect of nutraceuticals (+/- estrogen/tamoxifen), on proliferation of breast cancer cells and the relative expression of ERα/β.

Methods

Kelp, Astaxanthin, Saw Palmetto, Tocotrienols, Maca, Horsetail, Resveratrol, Curcumin and Ashwagandha were assessed on proliferation of MCF7, T47D and BT483 breast cancer cell lines +/- 17β-estradiol and tamoxifen. Each extract was analysed by high performance liquid chromatography (HPLC) prior to use. Cellular ERα and ERβ expression was assessed by qRT-PCR and western blot. Changes in the cellular localisation of ERα:ERβ and their ratio following incubation with the nutraceuticals was confirmed by immunocytochemistry.

Results

Estradiol stimulated DNA synthesis in three different breast cancer cell lines: MCF7, T47D and BT483, which was inhibited by tamoxifen; this was mirrored by a specific ERa agonist in T47D and BT483 cells. Overall, nutraceuticals did not interfere with tamoxifen inhibition of estrogen; some even induced further inhibition when combined with tamoxifen. The ERα:ERβ ratio was higher at mRNA and protein level in all cell lines. However, incubation with nutraceuticals induced a shift to higher ERβ expression and a localization of ERs around the nuclear periphery.

Conclusions

As ERα is the key driver of estrogen-dependent breast cancer, if nutraceuticals have a higher affinity for ERβ they may offer a protective effect, particularly if they synergize and augment the actions of tamoxifen. Since ERβ is the predominant ER in the hair follicle, further studies confirming whether nutraceuticals can shift the ratio towards ERβ in hair follicle cells would support a role for them in hair growth. Although more research is needed to assess safety and efficacy, this promising data suggests the potential of nutraceuticals as adjuvant therapy for hair loss in breast cancer patients receiving endocrine therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TamoxifenBreast NeoplasmsHumansFemaleEstrogen Receptor alphaEstrogen Receptor betaEstradiolEstrogensMCF-7 CellsDietary SupplementsAlopeciaHairCell Line, TumorCell Proliferation

Substanzen

TamoxifenEstrogen Receptor alphaEstrogen Receptor betaEstradiolEstrogens

Autor:innen und Institutionen

  • Centre for Skin Sciences, Faculty of Life Sciences, University of Bradford, Bradford, United Kingdom.
  • Nutraceutical Wellness, Inc. New York, NY, United States of America.

ORCID-Profile: Richard Baker

Förderung

  • Nutraceutical Wellness, Inc.

Zitieren

APA

Baker, R., Dell'Acqua, G., Richards, A., & Thornton, M. J. (2024). Nutraceuticals known to promote hair growth do not interfere with the inhibitory action of tamoxifen in MCF7, T47D and BT483 breast cancer cell lines. PLOS ONE. https://doi.org/10.1371/journal.pone.0297080

Vancouver

Baker R, Dell'Acqua G, Richards A, Thornton MJ. Nutraceuticals known to promote hair growth do not interfere with the inhibitory action of tamoxifen in MCF7, T47D and BT483 breast cancer cell lines. PLOS ONE. 2024. doi:10.1371/journal.pone.0297080

BibTeX
@article{Baker2024,
  author = {Baker, Richard and Dell'Acqua, Giorgio and Richards, Aleksander and Thornton, M Julie},
  title = {Nutraceuticals known to promote hair growth do not interfere with the inhibitory action of tamoxifen in MCF7, T47D and BT483 breast cancer cell lines},
  journal = {PLOS ONE},
  year = {2024},
  doi = {10.1371/journal.pone.0297080}
}
Kostenlos starten →